Heinrich-Heine Universitätsklinik Düsseldorf

Düsseldorf 40225

1 studies enrolling now · 3 studies all time

What they study most

NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Parkinson's Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
• A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease — Running, not enrolling
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed